These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17844703)

  • 1. A new strategy of drug treatment in NSAID--unresponsive ankylosing spondylitis.
    Chogle AR; Mishra H; Chakravarty A
    J Assoc Physicians India; 2007 May; 55():380; author reply 380-1. PubMed ID: 17844703
    [No Abstract]   [Full Text] [Related]  

  • 2. A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate.
    Malaviya AN; Kapoor S; Garg S; Ahmad I; Raja RR
    J Assoc Physicians India; 2007 Mar; 55():193-7. PubMed ID: 17598330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ankylosing spondylitis].
    El Maghraoui A
    Presse Med; 2004 Nov; 33(20):1459-64. PubMed ID: 15611681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical inquiries. Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis?
    Goodemote P; Jamieson B; Hoffman R
    J Fam Pract; 2007 Nov; 56(11):933-4, 937. PubMed ID: 17976342
    [No Abstract]   [Full Text] [Related]  

  • 5. The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis.
    Kang KY; Lee KY; Kwok SK; Ju JH; Park KS; Hong YS; Kim HY; Park SH
    Joint Bone Spine; 2011 Mar; 78(2):188-93. PubMed ID: 20621536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial.
    Santra G; Sarkar RN; Phaujdar S; Banerjee S; Siddhanta S
    Singapore Med J; 2010 Nov; 51(11):883-7. PubMed ID: 21140116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of uveitis and ankylosing spondylitis refractory to three tumor necrosis factor alpha inhibitors drugs with golimumab.
    Chaparro Sanabria JA; Bautista Molano W; Valle Oñate R
    Reumatol Clin (Engl Ed); 2020; 16(1):64-65. PubMed ID: 29472171
    [No Abstract]   [Full Text] [Related]  

  • 8. Ankylosing spondylitis associated with primary aldosteronism in a middle-aged woman.
    Suh YS; Kim HO; Cheon YH; Jo W; Hong J; Lee SI
    Korean J Intern Med; 2017 Mar; 32(2):374-377. PubMed ID: 26842104
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological treatment of ankylosing spondylitis: a systematic review.
    Boulos P; Dougados M; Macleod SM; Hunsche E
    Drugs; 2005; 65(15):2111-27. PubMed ID: 16225367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Andersson lesion in ankylosing spondylitis.
    Dhakad U; Das SK
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23559648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New-onset psoriasis associated with etanercept therapy.
    Chen LA; Su LH; Chang YJ; Hsu YL; Tsai TH
    J Dermatol; 2010 Apr; 37(4):378-80. PubMed ID: 20507411
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of refractory spondylarthropathies].
    Dubost JJ; Soubrier M; Sauvezie B
    Presse Med; 1998 Jan; 27(4):175-80. PubMed ID: 9768034
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of soluble cell adhesion molecules and soluble CD40 ligand levels in ankylosing spondylitis.
    Sari I; Alacacioglu A; Kebapcilar L; Taylan A; Bilgir O; Yildiz Y; Yuksel A; Kozaci DL
    Joint Bone Spine; 2010 Jan; 77(1):85-7. PubMed ID: 20022783
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid remission of treatment-resistant ankylosing spondylitis with etanercept--a drug for refractory ankylosing spondylitis?
    Barthel HR
    Arthritis Rheum; 2001 Aug; 45(4):404. PubMed ID: 11501730
    [No Abstract]   [Full Text] [Related]  

  • 15. Conventional DMARD therapy (methotrexate-sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: a real-life experience.
    Can M; Aydın SZ; Niğdelioğlu A; Atagündüz P; Direskeneli H
    Int J Rheum Dis; 2012 Dec; 15(6):526-30. PubMed ID: 23253235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Main symptom: chronic deep back pain. Do you know the signs of Bechterew disease?].
    MMW Fortschr Med; 2007 Jan; 149(4):13. PubMed ID: 17615709
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.
    Lie E; Kristensen LE; Forsblad-d'Elia H; Zverkova-Sandström T; Askling J; Jacobsson LT;
    Ann Rheum Dis; 2015 Jun; 74(6):970-8. PubMed ID: 25710471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic MEDLINE analysis of therapeutic approaches in ankylosing spondylitis.
    Goh L; Samanta A
    Rheumatol Int; 2009 Aug; 29(10):1123-35. PubMed ID: 19562344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies.
    Burgos-Vargas R; Vázquez-Mellado J; Pacheco-Tena C; Hernández-Garduño A; Goycochea-Robles MV
    Ann Rheum Dis; 2002 Oct; 61(10):941-2. PubMed ID: 12228171
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study.
    Biasi D; Carletto A; Caramaschi P; Pacor ML; Maleknia T; Bambara LM
    Clin Rheumatol; 2000; 19(2):114-7. PubMed ID: 10791621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.